inClinicois a platform for Data-driven multimodal forecast of single clinical trial's probability of success (PoS).
inClinico utilizes massive amounts of data about the targets, diseases, clinical trials, and even scientists involved with the study at the preclinical and clinical stages
Predict clinical trials success rate Recognize the weak points in trial design Adopt the best practices in the industry
Scoring of custom trials: compare designs for the clinical trial that are planned and optimize them for success
Database of historical and ongoing clinical trials: find clinical catalysts that drive pharmaceutical growth, sort them by the PoS, and research the designs of successful trials
Clinical Trial Outcome Scores: the ability to analyze performance for individual trials with simple data-driven metrics for the PoS Comprehensive Report Generation: customized reports with PoS and feature impacts on probabilities generated on inputs from OMICs data, drug structure, trial protocol, preclinical data, and publications, grants, and patents
Core Features
Customer profiles & Use cases
Buy-side analysts at pharma-focused funds
Search for the assets to invest in
Investment portfolio de-risking
BD&L executives at pharma companies
Technical due diligence for Mergers and Acquisitions, licensing and partnerships